Newsletter / Paid-only Round One to the EU & Friends: "Treaty" Option Gains Support By Priti Patnaik / 5 Nov 2021
Newsletter / Paid-only MSD's Pandemic Drug: The Big Moment for Voluntary Licensing; A Note on Editorial Positions By Priti Patnaik / 2 Nov 2021
Newsletter / Paid-only Pathogen-Sharing and the Access to Benefits: Theory And Practice By Priti Patnaik / 29 Oct 2021
Newsletter / Paid-only Global Health Governance Post-Pandemic: Forces of Fragmentation Meet Multilateralism By Priti Patnaik / 26 Oct 2021
Newsletter / Paid-only "Equity" Expands in Pandemic Treaty Discussions at WHO By Priti Patnaik / 22 Oct 2021
Newsletter / Paid-only Examining the “subtle shift” in the TRIPS Waiver talks By Priti Patnaik / 15 Oct 2021
Newsletter / Paid-only The ACT Accelerator Independent Review: A Missed Opportunity? By Priti Patnaik / 12 Oct 2021
Newsletter / Paid-only Review of International Health Regulations Makes Space in Treaty Talks; "Subtle Shift" in TRIPS Waiver Debate: WTO By Priti Patnaik / 8 Oct 2021
Newsletter / Paid-only The Dissonance Around a Pandemic Treaty; What the Damning Allegations in the DRC Mean for WHO; TRIPS Waiver Stalemate By Priti Patnaik / 5 Oct 2021
